Hormone Replacement Therapy for Menopausal Symptoms

Introduction to Hormone Replacement Therapy

• The American College of Obstetricians and Gynecologists recommends estrogen-only therapy for women with a hysterectomy and intact ovaries, specifically transdermal estradiol 50 μg daily, as it provides the most favorable risk-benefit profile without requiring progestin for endometrial protection 1, 2

Benefits of Estrogen-Only Therapy

• Estrogen-alone therapy in women without a uterus has a superior safety profile compared to combined estrogen-progestin therapy, including no increased breast cancer risk and potentially even a protective effect (hazard ratio 0.80) 3
• Estrogen therapy is the most effective intervention for vasomotor symptoms, reducing them by approximately 75% 4

Optimal Formulation and Dosing

• Transdermal estradiol should be the first-line choice over oral formulations because it avoids first-pass hepatic metabolism, reducing cardiovascular and thromboembolic risks, and has a more favorable profile on coagulation factors 2
• The recommended dose is 50 μg daily (0.05 mg/day patches changed twice weekly), which represents the lowest effective dose for symptom management 2

Risks and Contraindications

• Estrogen-alone therapy has modest risks, including a small increased risk of stroke (8 additional strokes per 10,000 women-years) and deep venous thrombosis 2, 3
• Absolute contraindications to screen for include history of breast cancer, active liver disease, history of myocardial infarction or coronary heart disease, history of stroke, and history of deep vein thrombosis or pulmonary embolism 2, 3

Monitoring and Follow-up

• Reassess symptom control and necessity of therapy every 3-6 months, and continue standard mammography screening 2
• Monitor for abnormal vaginal bleeding (though unlikely without a uterus) and assess bone health with adequate calcium and vitamin D supplementation 2

Estrogen Therapy for Post-Hysterectomy Menopausal Symptoms

Benefits and Risks

• The American College of Cardiology notes an increased gallbladder disease risk with estrogen therapy, with a small increase in venous thromboembolism 5

Contraindications to Screen For

• The American College of Physicians, as published in the Annals of Internal Medicine, recommends screening for absolute contraindications, including history of breast cancer or hormone-sensitive malignancy, and thrombophilic disorders 6

Non-Hormonal Alternatives

• The American College of Physicians, as published in the Annals of Internal Medicine, suggests evidence-based non-hormonal alternatives, including cognitive behavioral therapy, for patients with contraindications to estrogen therapy 6